Version 1
: Received: 8 May 2023 / Approved: 9 May 2023 / Online: 9 May 2023 (04:34:20 CEST)
Version 2
: Received: 19 June 2023 / Approved: 19 June 2023 / Online: 19 June 2023 (07:36:06 CEST)
Okazumi, S.; Oshiro, T.; Sasaki, A.; Matsubara, H.; Tatsuno, I. Verification of Safety and Efficacy of Sleeve Gastrectomy Based on National Registry by Japanese Society for Treatment of Obesity. J. Clin. Med.2023, 12, 4303.
Okazumi, S.; Oshiro, T.; Sasaki, A.; Matsubara, H.; Tatsuno, I. Verification of Safety and Efficacy of Sleeve Gastrectomy Based on National Registry by Japanese Society for Treatment of Obesity. J. Clin. Med. 2023, 12, 4303.
Okazumi, S.; Oshiro, T.; Sasaki, A.; Matsubara, H.; Tatsuno, I. Verification of Safety and Efficacy of Sleeve Gastrectomy Based on National Registry by Japanese Society for Treatment of Obesity. J. Clin. Med.2023, 12, 4303.
Okazumi, S.; Oshiro, T.; Sasaki, A.; Matsubara, H.; Tatsuno, I. Verification of Safety and Efficacy of Sleeve Gastrectomy Based on National Registry by Japanese Society for Treatment of Obesity. J. Clin. Med. 2023, 12, 4303.
Abstract
In Japan, bariatric surgical treatment was started in 1982. The Japanese Society for Treatment of Obesity(JSTO) was established in 2007 and then JSTO started national registry of bariatric surgery cases and multidisciplinary educational program. 44 facilities registered bariatric surgical cases. In this study, the purpose is to clarify the indication, the safety and the effectiveness of the sleeve gastrectomy using national registry data base compiled by JSTO. Preoperative BMI was ranged from 27 to 75, and the mean value was 42.2. As gender, men/women was 1/1.3. Age was 42.2 as mean. As preoperative complications, DM ratio was 56.1% of the patients, Hypertension 63.2%, dyslipidemia 65.2%, and sleep apnea syndrome 69.4%. As operation method, laparoscopic method were taken in 99.5% of the cases. The intra operative incidents rate was 1.3 %. Conversion rate to open method was 0.98%. Morbidity ratio was 9.8% and mortality was 0 %. Reoperations were performed in 1.5 % of the cases. Postoperative hospital stay was 3.5 days in Median value. Body weight loss was 27.2 kg in the mean value after follow up days of 286 (fig.10). As the effect on the preoperative metabolic complications, DM has improved in 86.9 % of the cases, Hypertension 68.7 % and Dyslipidemia 67.9%. In conclusion, the usefulness of sleeve gastrectomy has been shown and verified that it is safely administered in Japan
Keywords
national registry; bariatric surgery; sleeve gastrectomy; safety; efficacy
Subject
Arts and Humanities, Humanities
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
